Zacks Investment Research upgraded shares of Eurofins Scient (OTCMKTS:ERFSF) from a hold rating to a strong-buy rating in a research report sent to investors on Thursday, November 2nd. The firm currently has $717.00 price target on the stock.
According to Zacks, “Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. “
Shares of Eurofins Scient (OTCMKTS ERFSF) opened at $607.15 on Thursday. Eurofins Scient has a 1-year low of $413.57 and a 1-year high of $649.22.
WARNING: “Eurofins Scient (NASDAQ:ERFSF) Upgraded by Zacks Investment Research to “Strong-Buy”” was reported by BBNS and is owned by of BBNS. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://baseballnewssource.com/markets/eurofins-scientifi-erfsf-lifted-to-strong-buy-at-zacks-investment-research/1753617.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with our FREE daily email newsletter.